Atazanavir (ATV)

DRUG3 trials

Sponsors

International Maternal Pediatric Adolescent AIDS Clinical Trials Group, University of North Carolina, Chapel Hill, ViiV Healthcare

Conditions

HIV InfectionsHuman Immunodeficiency Virus

Phase 2

Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults

TerminatedNCT02386098

ViiV HealthcareHIV Infections

Start: 2015-07-08End: 2017-06-07Updated: 2018-08-20

Unknown Phase

IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults

CompletedNCT00977756

International Maternal Pediatric Adolescent AIDS Clinical Trials GroupHIV Infections

Start: 2002-08-31End: 2014-03-31Updated: 2015-08-07

Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population

CompletedNCT01180075

University of North Carolina, Chapel HillHuman Immunodeficiency Virus

Start: 2010-05-31End: 2014-08-31Updated: 2014-12-02

Related Papers

Tenofovir/Emtricitabine Metabolites and Endogenous Nucleotide Exposures are associated with p16<sup>INK4a</sup> Expression in Subjects on Combination Therapy

Antiviral Therapy2015-07-015 citations